the present invention relates to a bioresorbable scaffold for a vascular stent comprising a nitric oxide agonist and a polymer comprising a lactide , a glycolide and a lactone . the nitric oxide agonist is a statin or a hmg coa reductase inhibitor . the nitric oxide agonist may be coated on the polymer , incorporated within the polymer or chemically bonded to the polymer . the invention also relates to a method for treating atherothrombosclerotic occlusive disease of an artery comprising implanting into the artery a stent with a bioresorbable scaffold comprising a nitric oxide agonist and a polymer comprising a lactide , a glycolide and a lactone , wherein the nitric oxide agonist is exuded from or released from the bioresorbable scaffold .